INTERNATIONAL PATENT: INTELLIA THERAPEUTICS, INC. FILES APPLICATION FOR "CD8 CO-RECEPTOR CHIMERIC POLYPEPTIDES IN TCR CELL THERAPY"

GENEVA, Dec. 17 -- INTELLIA THERAPEUTICS, INC. (40 Erie StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/032394) for "CD8 CO-RECEPTOR CHIMERIC POLYPEPTIDES IN TCR CELL THERAPY" on Jun 05, 2025. With publication no. WO/2025/255308, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHULTES, Birgit (c/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, Massachusetts 02139), PRODEUS, Aaron (c/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, Massachusetts 02139)

Abstract: Chimeric CD8 polypep...